Save the Date 2011
1 2 3
The Season PB
|E-mail this page to your
Black Tie International:
Club NYC 16th Anniversary Benefit Gala
Club New York City 15th Anniversary Gala –
November 18, 2010 – The Pierre Hotel Lily Safani, CEO;
Honorees, Elliott Sigal, M.D., Ph.D., Bristol-Myers Squibb,
Andrew J. Dannenberg, M.D., Weill Cornell Cancer Center;
Robert J. Easton, GCNYC Gala and Board Chair.
by: Rob Wayne
Celebrating 16 Years of
Cancer Support at Gilda’s Club NYC
Gilda's Club New
York City (GCNYC) will honor
Dr. David Schenkein, Dr. James Allison, and ID Media
on Thursday, November 17, 2011 at their 16th
Anniversary Benefit Gala. This exciting affair will be held
the renowned Pierre Hotel.
The evening will begin with a cocktail hour
and silent auction,
followed by a formal dinner, award ceremony and live auction. Donations
made will enable GCNYC to raise awareness and
help fulfill its mission to provide social and emotional
support for everyone living with cancer in New York City,
their families and friends –
FREE of charge.
is proud to honor two visionaries at this year’s event,
whose work has helped
individuals diagnosed with cancer,
MD, Chief Executive Officer, Agios
and James Allison, PhD, Chairman,
Sloan-Kettering Cancer Center.
of these individuals have helped shape the course
of medicine for thousands of patients living with cancer
and their families.
Dr. Schenkein joined
Agios in 2009 as
the CEO and has been a hematologist and medical oncologist
for more than 20 years. He has published more than
75 peer-reviewed articles. Under his leadership as the
head of oncology drug development at Millennium and
Genentech, multiple novel and important oncology medicines
have come to market. Agios is passionately committed to the fundamental
transformation of cancer patients’ lives through
scientific leadership in the field of cancer metabolism.
Allison is a leader
in the field of immunology, particularly in developing ways
to help the immune system recognize
and destroy cancer cells. His research is focused on the
mechanisms that regulate the immunological response of
T lymphocytes. He found a molecule, CTLA-4 that plays a
critical role in turning off T cells. He went on to show
antibodies to CTLA-4 could induce rejection of tumors in
preclinical animal models. Allison was involved in the
generation of antibodies to human CTLA-4 which have been
extensively tested in clinical trials in a variety of human cancers.
It was recently shown to significantly increase survival in
late stage melanoma patients, with about 25% surviving 4+ years.
This antibody, Ipilimumab, was the first drug ever to show
survival benefit in late stage melanoma.
It was recently approved by the Food and Drug Administration
for the treatment of melanoma.
In addition, a
special presentation of
Bill Modell Heart of
Gold Award” will be made to ID Media
for their outstanding volunteer efforts within our
GCNYC is proud to
host the event
for her seventh year in a row. “We are honored to have
Diana’s continued support as part of this important event,
help us share our story,” said Lily Safani, CEO of GCNYC.
A new addition to the evening is our auctioneer,
C. Hugh Hildesley, from Sotheby’s.
Gilda’s Club New
York City creates welcoming
Houston Street in Manhattan, and we have seven sites
of free support for everyone living with cancer - men, women,
teens and children - along with their families and friends. Our innovative
program is an essential complement to medical care,
providing networking and support groups, workshops,
lectures and social activities, all
free of charge. We provide our program in
beautiful, non-residential homelike settings:
our clubhouse is a four-story brownstone on
in Brooklyn and the Bronx as part of our community
www.gildasclubnyc.org for more
Back to Home